Oct 06, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment
IceCure Medical shares surge after FDA clears ProSense, marking the first minimally invasive breast cancer treatment for women aged 70 and above.
Sep 29, 2025 • Zacks Commentary
BULLISH
Here's Why Envista ( NVST ) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Sep 29, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Bio-Techne Stock Climbs on Advances in Spatial Biology Solutions
TECH shares rise as advances in RNAscope and COMET spotlight new roles in lymphoid malignancy diagnostics.
Sep 29, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis
Heartflow secures FDA clearance and Cigna coverage for its Next Gen Plaque Analysis, boosting accuracy and nationwide access.
Sep 26, 2025 • Zacks Commentary
BULLISH
NVST vs. ABT: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either Envista ( NVST Quick QuoteNVST - ) or Abbott ( ABT Quick QuoteABT - ) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
Sep 26, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent
GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus' PSMA PET imaging agent, PYLARIFY, for commercialization in Japan.